The follow-up problem in homoeopathic practice

Start from the clinical fact rather than any statistic. A chronic case is managed across time: the first prescription is an hypothesis, the follow-up is where it is tested, and the second prescription — in the proper sense of that term, the remedy chosen after the first has finished acting — depends entirely on the patient coming back so the comparison can be made. A chronic treatment plan is a year of appointments pretending to be one prescription. Everything below follows from that.

What the Indian studies show

Four independent Indian datasets, all from monitored settings, agree on the shape. We present them with their caveats, because a number without its caveat is marketing:

• A CCRH psoriasis study — 384 patients across 11 centres, 2014–2019 — reported participant attrition of "33.85% in the first year and 78.12% by the end of 2 years".
• A CCRH vitiligo study across 11 institutes enrolled 361 participants; 266 completed one year, 139 continued a second, and 62 completed three years. That is about one in six over three years — our arithmetic; the paper itself states no percentage.
• Fourteen CCRH outpatient clinics recorded 2,811 patients in the study window, of whom 2,468 were new; outcome forms based on one or more follow-ups existed for 868, and the number of follow-ups per patient "varied from 1 to 13". Caveat: the window spans the COVID lockdowns, and any ratio derived from those counts is our derivation, not the paper's.
• A West Bengal homoeopathic hospital logged 878 appointments across 429 patients — roughly two visits per patient on average.

Two honesty notes before anyone quotes these. First, these were monitored, free-of-cost study cohorts with follow-up protocols and staff whose job included keeping participants enrolled; there is no obvious reason ordinary fee-paying private practice would do better. Second — and this matters — we could not find a single Indian practitioner saying "my patients don't come back" in their own published words. The numbers are academic; the voice is missing. We would rather admit that than manufacture the quote. (You will find vivid no-show percentages — 15%, 30%, 40% — on clinic-software marketing sites. None that we examined cites a source, so none of them appears here.)

Why patients stop, and why one reason is not a problem

Patients stop coming for many reasons — distance, money, a demanding season on the farm or at work, or the complaint quietly resolving. And one reason deserves special care, because software marketing routinely gets it wrong: in classical practice, stopping the medicine on improvement is often the doctor's own instruction. As Dr Prabha Acharya, MD, puts it in published patient guidance:

"When individuals start feeling better after the course of the homeopathic treatment, the dose should be stopped."

So the problem to solve is not "patients don't finish their medicine" — a framing borrowed from another system of prescribing, and clinically wrong here. The problem is that stopping the medicine and disappearing from the case are different things, and the second often rides in on the first. The patient who felt better and correctly stopped the dose also skips the follow-up — and with it goes the doctor's chance to see what the remedy actually did, record it, and decide what comes next. The case record ends mid-sentence.

What a clinic can actually do about it

No software makes patients come back, and we would distrust any that claimed to. What a clinic system can do is remove the mechanical reasons the thread breaks:

• The follow-up is scheduled the day the prescription is made, not left to "come after a month". In Homoeoclinics, follow-up reminders come back to the clinic — so a lapsed follow-up is a visible item on the clinic's list, not a silence nobody notices.
• The patient carries the clinic in their pocket. The patient app holds their prescription, their upcoming appointment, and booking — so returning does not depend on a paper chit surviving three months on a kitchen shelf.
• Some follow-ups don't need a trip at all. Book the appointment as online and a Google Meet link is generated and shared automatically — one less reason distance, a demanding season at work, or the cost of travel turns into a missed visit.
• Dose reminders deliver the schedule you set — and only that. What the patient takes, for how long, and when to stop remains the doctor's instruction; the app is the messenger, never the author. If your instruction is "stop on improvement and come show me", that is what the reminder supports.
• When someone does return after a gap, the record is ready. The original totality, the remedy, the potency and the date are attached to the case — so a patient re-appearing after eight months is a follow-up, not a re-taking from memory. (More on that in the case-record article.)
• Announcements reach every patient at once — changed timings, a closure, a camp — so the clinic staying in touch does not depend on one phone call at a time.

The honest claim ends there. Attrition has causes no reminder touches, and the studies above measure settings with more follow-up machinery than most software will ever provide. What a well-kept system changes is the marginal case: the patient who meant to come back, and the clinic that would have noticed they hadn't.